Published ahead of print on November 14, 2008, doi:10.1164/rccm.200805-722OC
American Journal of Respiratory and Critical Care Medicine Vol 179. pp. 220-227, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200805-722OC
Has Mortality from Acute Respiratory Distress Syndrome Decreased over Time?A Systematic Review
Jason Phua1,2,
Joan R. Badia1,3,
Neill K. J. Adhikari1,4,
Jan O. Friedrich1,5,
Robert A. Fowler1,4,
Jeff M. Singh1,6,
Damon C. Scales1,4,
David R. Stather7,
Amanda Li8,
Andrew Jones9,
David J. Gattas10,
David Hallett1,
George Tomlinson1,
Thomas E. Stewart1,6 and
Niall D. Ferguson1,6
1 Interdepartmental Division of Critical Care, University of Toronto, Toronto, Ontario, Canada; 2 Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, Singapore, Singapore; 3 Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Biomedical Research Centres Network of Respiratory Diseases, Barcelona, Spain; 4 Department of Critical Care Medicine, Sunnybrook Health Science Centre, Toronto, Ontario, Canada; 5 Critical Care and Medicine Departments, and The Keenan Research Centre in The Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; 6 Department of Medicine, Division of Respirology, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada; 7 Department of Medicine, Division of Respirology, University of Calgary, Alberta, Canada; 8 University of Ottawa, Ontario, Canada; 9 Department of Critical Care, Guy's & St. Thomas NHS Foundation Trust, London, United Kingdom; and 10 Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Correspondence and requests for reprints should be addressed to Dr. Niall D. Ferguson, M.D., F.R.C.P.C., M.Sc., Toronto Western Hospital, 399 Bathurst Street, 2MCL-411M, Toronto, ON M5T 2S8, Canada. E-mail: n.ferguson{at}utoronto.ca
Rationale: It is commonly stated that mortality from acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) is decreasing.
Objectives: To systematically review the literature assessing ARDS mortality over time and to determine patient- and study-level factors independently associated with mortality.
Methods: We searched multiple databases (MEDLINE, EMBASE, CINAHL, Cochrane CENTRAL) for prospective observational studies or randomized controlled trials (RCTs) published during the period 1984 to 2006 that enrolled 50 or more patients with ALI/ARDS and reported mortality. We pooled mortality estimates using random-effects meta-analysis and examined mortality trends before and after 1994 (when a consensus definition of ALI/ARDS was published) and factors associated with mortality using meta-regression models.
Measurements and Main Results: Of 4,966 studies, 89 met inclusion criteria (53 observational, 36 RCTs). There was a total of 18,900 patients (mean age 51.6 years; 39% female). Overall pooled weighted mortality was 44.3% (95% confidence interval [CI], 41.8–46.9). Mortality decreased with time in observational studies conducted before 1994; no temporal associations with mortality were demonstrated in RCTs (any time) or observational studies (after 1994). Pooled mortality from 1994 to 2006 was 44.0% (95% CI, 40.1–47.5) for observational studies, and 36.2% (95% CI, 32.1–40.5) for RCTs. Meta-regression identified study type (observational versus RCT, odds ratio, 1.36; 95% CI, 1.08–1.73) and patient age (odds ratio per additional 10 yr, 1.27; 95% CI, 1.07–1.50) as the only factors associated with mortality.
Conclusions: A decrease in ARDS mortality was only seen in observational studies from 1984 to 1993. Mortality did not decrease between 1994 (when a consensus definition was published) and 2006, and is lower in RCTs than observational studies.
Key Words: acute lung injury meta-analysis prognosis survival
| AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
It is commonly stated and assumed that mortality from acute respiratory distress syndrome (ARDS) is decreasing.
What This Study Adds to the Field
We found that mortality from ARDS has not decreased substantially since the publication of a consensus definition in 1994. Based on our findings, a baseline mortality risk from ARDS of 40 to 45% for observational studies and 35 to 40% for randomized control trials should be expected. These results highlight the need for future effective therapeutic interventions for this highly lethal syndrome.
|
Related articles in AJRCCM:
- Changing Mortality in Acute Respiratory Distress Syndrome? Yes, We Can!
- Laurent Brochard and Jean-Jacques Rouby
AJRCCM 2009 179: 177-178.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
C. C. J. Zavitz, C. M. T. Bauer, G. J. Gaschler, K. M. Fraser, R. M. Strieter, C. M. Hogaboam, and M. R. Stampfli
Dysregulated Macrophage-Inflammatory Protein-2 Expression Drives Illness in Bacterial Superinfection of Influenza
J. Immunol.,
February 15, 2010;
184(4):
2001 - 2013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Floerchinger, A. Philipp, M. Foltan, L. Rupprecht, A. Klose, D. Camboni, F. Bruenger, S. Schopka, M. Arlt, M. Hilker, et al.
Switch From Venoarterial Extracorporeal Membrane Oxygenation to Arteriovenous Pumpless Extracorporeal Lung Assist.
Ann. Thorac. Surg.,
January 1, 2010;
89(1):
125 - 131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Frey
Incidence and Prevention of ARDS: A Measure of Progress
Am. J. Respir. Crit. Care Med.,
December 1, 2009;
180(11):
1158 - 1158.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Phua, J. R. Badia, N. K. J. Adhikari, R. A. Fowler, D. C. Scales, and N. D. Ferguson
Are Outcomes Improving in Patients with ARDS?
Am. J. Respir. Crit. Care Med.,
December 1, 2009;
180(11):
1159 - 1159.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zambon and J.-L. Vincent
Are Outcomes Improving in Patients with ARDS?
Am. J. Respir. Crit. Care Med.,
December 1, 2009;
180(11):
1158 - 1159.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Taccone, A. Pesenti, R. Latini, F. Polli, F. Vagginelli, C. Mietto, L. Caspani, F. Raimondi, G. Bordone, G. Iapichino, et al.
Prone Positioning in Patients With Moderate and Severe Acute Respiratory Distress Syndrome: A Randomized Controlled Trial
JAMA,
November 11, 2009;
302(18):
1977 - 1984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dominguez-Cherit, S. E. Lapinsky, A. E. Macias, R. Pinto, L. Espinosa-Perez, A. de la Torre, M. Poblano-Morales, J. A. Baltazar-Torres, E. Bautista, A. Martinez, et al.
Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico
JAMA,
November 4, 2009;
302(17):
1880 - 1887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Boe, R. W. Vandivier, E. L. Burnham, and M. Moss
Alcohol abuse and pulmonary disease
J. Leukoc. Biol.,
November 1, 2009;
86(5):
1097 - 1104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-Y. Chen, K.-Y. Yang, M.-Y. Chen, H.-Y. Chen, M.-T. Lin, Y.-C. Lee, R.-P. Perng, S.-L. Hsieh, P.-C. Yang, and T.-Y. Chou
Decoy Receptor 3 Levels in Peripheral Blood Predict Outcomes of Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med.,
October 15, 2009;
180(8):
751 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Liu, H. Li, J. Cepeda, Y. Xia, J. A. Kempf, H. Ye, L. Q. Zhang, and S. Q. Ye
Regulation of Inflammatory Cytokine Expression in Pulmonary Epithelial Cells by Pre-B-cell Colony-enhancing Factor via a Nonenzymatic and AP-1-dependent Mechanism
J. Biol. Chem.,
October 2, 2009;
284(40):
27344 - 27351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Prows, A. V. Winterberg, W. J. Gibbons Jr., B. B. Burzynski, C. Liu, and T. G. Nick
Reciprocal backcross mice confirm major loci linked to hyperoxic acute lung injury survival time
Physiol Genomics,
July 9, 2009;
38(2):
158 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2009 American Thoracic Society
|
|
|